"An nCompass Device Support Specialist (DSS) came to teach us about applying the arrays, setting up the device, and managing my treatment."
Gene, an Optune® user and Patient Ambassador

nCompass™ logo

Get support every step of the way

We know that starting Optune doesn't just impact how you treat your GBM. It can impact your entire way of life, and that can be a lot to deal with—that's where nCompass comes in. Our support team is here to help as you adjust to life with Optune, and we're available 24/7.

Contact us 24/7

Contacting Optune®

Call us:
1-855-281-9301 (toll free)

Contacting Optune®

Or email us:
support@novocure.com

Support is available in over 240 languages.

Starting Optune®

After your doctor prescribes Optune, nCompass will:

  • Call you to discuss next steps and answer your questions
  • Work with your insurance plan and identify resources that may help minimize your cost
  • Set up delivery of Optune and provide training to you and your caregivers
24 hour resources

During treatment with Optune, nCompass is one call away to:

  • Set up additional Optune training at any time if you need it
  • Provide tips and resources on how to make Optune a part of your daily life
  • Answer questions about how Optune works and its possible side effects
  • Troubleshoot any technical issues
  • Reorder supplies, such as arrays or extra batteries
  • Offer travel tips and resources
  • Provide support and answer questions 24/7

24/7 support

See how nCompass can help with
24/7 support.

Device Support Specialists (DSS)

Discover how your DSS can be your
go-to source for Optune information and instructions.

"Everyone I spoke to at nCompass was kind, patient, and compassionate. They became my best friends, partly because I called them so often, especially in the beginning!"
— Pat, an Optune user and Patient Ambassador

What is Optune® approved to treat?

Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.

Newly diagnosed GBM

If you have newly diagnosed GBM, Optune is used together with a chemotherapy called temozolomide (TMZ) if:

Recurrent GBM

If your tumor has come back, Optune can be used alone as an alternative to standard medical therapy if:

What is Optune Lua approved to treat?

Optune Lua is a wearable, portable, FDA-approved device indicated for the treatment of adult patients, with unresectable, locally advanced or metastatic, malignant pleural mesothelioma (MPM) to be used together with standard chemotherapy (pemetrexed and platinum-based chemotherapy).

Who should not use Optune for GBM or Optune Lua for MPM?

Optune for GBM and Optune Lua for MPM are not for everyone. Talk to your doctor if you have:

Do not use Optune for GBM or Optune Lua for MPM if you are pregnant or are planning to become pregnant. It is not known if Optune/Optune Lua is safe or effective during pregnancy.

What should I know before using Optune for GBM or Optune Lua for MPM?

Optune and Optune Lua should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure®, the maker of Optune and Optune Lua.

What are the possible side effects of Optune for GBM and Optune Lua for MPM?

The most common side effects of Optune when used together with chemotherapy for GBM (temozolomide or TMZ) were low blood platelet count, nausea, constipation, vomiting, tiredness, seizure, and depression.

The most common side effects when using Optune alone for GBM were scalp irritation (redness and itchiness) and headache. Other side effects were malaise, muscle twitching, fall and skin ulcers.

The most common side effects of Optune Lua when used together with chemotherapy for MPM (pemetrexed and platinum-based chemotherapy) were low red blood cell count, constipation, nausea, tiredness, chest pain, fatigue, skin irritation from device use, itchy skin, and cough.

Other potential adverse effects associated with the use of Optune Lua include: treatment related skin irritation, allergic reaction to the plaster or to the gel, electrode overheating leading to pain and/or local skin burns, infections at sites of electrode contact with the skin, local warmth and tingling sensation beneath the electrodes, muscle twitching, medical device site reaction and skin breakdown/skin ulcer.

Talk to your doctor if you have any of these side effects or questions.

Caution: Federal law restricts Optune Lua to sale by or on the order of a physician. Humanitarian Device. Authorized by Federal Law for use in the treatment of adult patients with unresectable, locally advanced or metastatic, malignant pleural mesothelioma concurrently with pemetrexed and platinum-based chemotherapy. The effectiveness of this device for this use has not been demonstrated.

Please click here to see the Optune Instructions for Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.

Please click here to see the Optune Lua IFU for complete information regarding the device's indications, contraindications, warnings, and precautions.

On this site, patient and healthcare professional videos as well as all images labeled as Optune users, caregivers, or healthcare professionals depict actual patients, caregivers, and healthcare professionals. All other depictions of patients and caregivers are actor portrayals. Patient images reflect the health status of the patients at the time each photo was taken.

What is Optune approved to treat?

Optune is indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.